evidencegaps
Primary study · included by 1 review

Denosumab for central giant cell granuloma in an Australian tertiary paediatric centre.

Vanderniet et al. 2022 · Vanderniet Joel A, Wall Christie-Lee, Mullins Anna, et al. · Bone · 2022

Included by

RANK/RANKL/OPG Axis Expression and Response to Anti-RANKL Therapy in Gnathic Giant Cell Lesions: A Systematic Review and Meta-Analysis.
Non-Cochrane · other · 2026 · cited as Vanderniet 2022 · Table 2; Table 1 / Table 4; reference list
Outcome this study informsPooled effectEvidenceCertainty
Clinical and radiological tumor response
Denosumab
no estimate extracted10 studies · 58 participantsGRADE not reported

1 including review in total.